Sentara Neurology Specialists

Virginia Beach, Virginia 23456

2 studies enrolling now · 16 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis, Chronic Migraine, Dyskinesia, Drug-Induced, Dyskinesias, Focal Epilepsy, Focal Onset Seizures, Lewy Body Dementia, Migraine, Migraine, With or Without Aura, Orthostatic Hypotension, Parkinson Disease

Studies at this site

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy — Stopped early
An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) — Completed
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease — Stopped early
Study of Urate Elevation in Parkinson's Disease, Phase 3 — Completed
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
Efficacy of Isradipine in Early Parkinson Disease — Completed
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 — Status unconfirmed
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease — Completed